Amneal Pharmaceuticals, Inc.

AMRX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$74-$49-$255$11
Dep. & Amort.$236$229$240$233
Deferred Tax$0$0$0$0
Stock-Based Comp.$28$27$32$0
Change in WC-$4-$47-$60-$134
Other Non-Cash$109$185$108$131
Operating Cash Flow$295$346$65$242
Investing Activities
PP&E Inv.-$60-$47-$49-$49
Net Acquisitions$12$0-$85-$142
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$15-$22-$41-$3
Investing Cash Flow-$63-$69-$174-$194
Financing Activities
Debt Repay.-$185$23-$38-$79
Stock Issued$0$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$27-$235-$68-$60
Financing Cash Flow-$212-$213-$107-$138
Forex Effect-$1$0-$6$0
Net Chg. in Cash$19$64-$222-$90
Supplemental Information
Beg. Cash$99$35$257$347
End Cash$118$99$35$257
Free Cash Flow$220$276-$25$194